Provided by Tiger Trade Technology Pte. Ltd.

Agilent

153.35
-0.4900-0.32%
Volume:766.02K
Turnover:116.90M
Market Cap:43.41B
PE:30.24
High:153.39
Open:152.09
Low:151.64
Close:153.84
52wk High:163.75
52wk Low:108.35
Shares:283.05M
Float Shares:281.64M
Volume Ratio:0.28
T/O Rate:0.27%
Dividend:1.01
Dividend Rate:0.66%
EPS(TTM):5.07
EPS(LYR):4.59
ROE:20.97%
ROA:8.72%
PB:5.90
PE(LYR):33.42

Loading ...

Agilent Technologies (A) Wins FDA Approval, Where Does Fair Value Sit Now?

Simply Wall St.
·
Jul 21

Mettler-toledo International Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 21

DT Cloud Star Acquisition Corporation Receives Nasdaq Delist Determinization Letter

GlobeNewswire
·
Jul 21

Revvity Inc. Stock Slides 3.4%, Underperforms Peers

Dow Jones
·
Jul 21

FDA-Approved PD-L1 Test for GI Cancers Could Be A Game Changer For Agilent Technologies (A)

Simply Wall St.
·
Jul 19

Mettler-toledo International Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Jul 18

Helport AI Limited Receives Standard Nasdaq Notification Regarding Minimum Bid Price Requirement

GlobeNewswire
·
Jul 18

Huadi International Group Co., Ltd. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

GlobeNewswire
·
Jul 17

Guangdong Announces 3,180 Yuan Dental Subsidy for Residents, Open to Ages 6 and Up

Deep News
·
Jul 17

Probly Announces Its Prediction-Market Integration With TxFlow L1

utoday
·
Jul 17

Agilent Technologies Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jul 17

Cycurion Receives Nasdaq Delisting Determination Letter; Appeal Underway, Trading to Continue, Focus on Shareholder Value

GlobeNewswire
·
Jul 17

Agilent Bdrs in Brazil Set for 4-for-1 Stock Split, Ratio Shifts to 1:10

Reuters
·
Jul 16

Mettler-toledo International Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 15

Agilent Wins FDA Approval for PD-L1 IHC 28-8 Test in Gastric and Esophageal Cancers

Reuters
·
Jul 14

Agilent Receives FDA Approval for Pd-l1 Ihc 28-8 Pharmdx in Esophageal Squamous Cell Carcinoma (escc), Gastric, Gastroesophageal Junction (gej), and Esophageal Adenocarcinoma

THOMSON REUTERS
·
Jul 14

Revvity Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 14

Baird Adjusts Agilent Technologies Price Target to $160 From $158, Maintains Outperform Rating

MT Newswires Live
·
Jul 13

Admission to Trading

GlobeNewswire
·
Jul 11

Figure Technology Solutions Announces Pricing of Private Offering of $600 Million of Senior Notes

GlobeNewswire
·
Jul 10